The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Fasinumab is from a class of drugs targeting nerve growth factor (NGF), which plays a central role in the regulation of pain signalling. The FDA had trials of NGF drugs on hold twice because of ...